Different hypotheses have been postulated for the progression of AD
The condition can lead to loss of eyesight due to the optic nerve being deprived of oxygen and subsequently damaged
community sources describe keeping fast-acting carbs available Organ growth gut distension and cardiomegaly possible with prolonged, high-dose use Jaw and hand growth subtle acromegaly-like changes with chronic use Cancer risk chronically elevated IGF-1 is associated with increased cancer risk in epidemiological studies Joint pain connective tissue changes, water retention Fatigue/lethargy common, especially initially Injecting before sleep community sources warn against this, as hypoglycemia during sleep is dangerous mg to Units Conversion On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL)
No immediate or predictable energy benefit has been established
Dulaglutide and liraglutide show intermediate efficacy with A1c reductions of approximately 1.01.5%, while exenatide twice daily demonstrates somewhat more modest effects
Data was acquired in positive mode using parallel reaction monitoring with an inclusion list of acylcarnitines of interest (see Supplementary Table S4)